Filter By

Achieving an Aggressive NDA Timeline

Imagine you are completing your regulatory submission project with only nine months left until submission day and you still have to migrate legacy data into SDTM format for 18 studies as well as 2 ongoing pivotal studies. 

Case Study

Exceeding Expectations For Patient Enrollment Case Study

When Veristat partnered with a US based biotechnology company on a Phase II study for a topical spray to treat hypertension, our emphasis on effective planning and management led to overwhelming success.

Case Study

Guiding an Oncology Program to Success

A clinical stage biotech firm engaged Veristat to run their very first ever clinical trial, a phase I US only oncology trial. When the project started, the client was a three-person team. Veristat was and still is the entire project team and we have and continue to work with this client to guide them and train them through the clinical trial process.

Case Study

Improving Patient Recruitment

Patient recruitment delays are common challenges in clinical trials that can lead to costly delays. In fact, nearly 80 percent of patient recruitment timelines in clinical trials are not met and over 50 percent of the patients are not enrolled within the planned timeframes.

Case Study

Keeping Up with an Over-Performing Site Case Study

Find out how Veristat was able to expertly rescue the site management and monitoring activities for a  sponsor seven months into patient enrollment at the site by utilizing our adaptable project managers and monitoring services.

Case Study

Preparing An NDA Submission For A Purchased Cancer Compound 

Veristat's dynamic teams of regulatory experts and experienced medical writers are problem solvers that can guide you to regulatory approval.

Case Study

Quick Feasibility Assessment to Expand Trial Into Europe Case Study

Veristat provides a feasibility assessment to a clinical stage biotechnology firm who wants to know whether it is feasible  to expand their current US study into European sites. Being an oncology study, the trial had some very specific technology requirements for the site and part of the assessment was to determine if that technology was available at sites in Europe

Case Study

Running Successful Clinical Programs with an External Biostatistics TeamRunning Successful Clinical Programs with an External Biostatistics Team

A biopharmaceutical firm specializing in rare and ultra-rare disease research started working with Veristat over 7 years ago.

Case Study

Site Monitoring Success With Teamwork

Imagine you are getting ready to launch the third drug cohort of your early phase clinical trial for a pancreatic cancer vaccine study and your in-house lead CRA overseeing your sites in Europe retires. This happened to our client, who brought on Veristat to transition and seamlessly continue monitoring for the sites in this cohort.

Case Study